Evidence map›Paper›PMID 36916200›Full record

ReviewTechnology in cancer research & treatment

Ablative Therapies for Breast Cancer: State of Art.

Serena Carriero, Carolina Lanza, Giuseppe Pellegrino, Velio Ascenti, Caterina Sattin, Caterina Pizzi, Salvatore Alessio Angileri, Pierpaolo Biondetti, Andrea Antonio Ianniello, Filippo Piacentino and 3 more

Abstract readReview
In one paragraph

Review in Technology in cancer research & treatment. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Review
  5. Aging and cancer: current understandings and future perspectives.Signal transduction and targeted therapy · 2026
    Review
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Review
  17. Article
  18. Prospects of Synergy: Local Interventions and CAR T Cell Therapy in Solid Tumors.BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy · 2024
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Serena CarrieroPostgraduate School of Radiodiagnostics, Università degli Studi di Milano, Milan, Italy.ORCID 0000-0003-2583-4215
Carolina LanzaPostgraduate School of Radiodiagnostics, Università degli Studi di Milano, Milan, Italy.
Giuseppe PellegrinoPostgraduate School of Radiodiagnostics, Università degli Studi di Milano, Milan, Italy.
Velio AscentiPostgraduate School of Radiodiagnostics, Università degli Studi di Milano, Milan, Italy.ORCID 0000-0001-8041-4075
Caterina SattinPostgraduate School of Radiodiagnostics, Università degli Studi di Milano, Milan, Italy.
Caterina PizziPostgraduate School of Radiodiagnostics, Università degli Studi di Milano, Milan, Italy.
Salvatore Alessio AngileriDepartment of Diagnostic and Interventional Radiology, Fondazione IRCCS Cà Granda, Policlinico di Milano Ospedale Maggiore, Via Sforza 35, 20122 Milan, Italy.
Pierpaolo BiondettiDepartment of Diagnostic and Interventional Radiology, Fondazione IRCCS Cà Granda, Policlinico di Milano Ospedale Maggiore, Via Sforza 35, 20122 Milan, Italy.
Andrea Antonio IannielloDepartment of Diagnostic and Interventional Radiology, Ospedale Luigi Sacco, Milan, Italy.
Filippo PiacentinoDepartment of Diagnostic and Interventional Radiology, Ospedale di Circolo, Varese, Italy.
Roberto LavoratoResearcher at Diagnostic and Interventional Radiology Department, 9339IRCCS Ca' Granda Fondazione Ospedale Maggiore Policlinico, Milan, Italy.
Anna Maria IerardiDepartment of Diagnostic and Interventional Radiology, Fondazione IRCCS Cà Granda, Policlinico di Milano Ospedale Maggiore, Via Sforza 35, 20122 Milan, Italy.
Gianpaolo CarrafielloDepartment of Diagnostic and Interventional Radiology, Fondazione IRCCS Cà Granda, Policlinico di Milano Ospedale Maggiore, Via Sforza 35, 20122 Milan, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Breast cancer (BC) is the most frequently diagnosed malignancy among women. In the past two decades, new technologies and BC screening have led to the diagnosis of smaller and earlier-stage BC (ESBC). Therefore, percutaneous minimally invasive techniques (PMIT) were adopted to treat patients unfit for surgery, women who refuse it, or elderly patients with comorbidities that could make surgery a difficult and life-threatening treatment. The target of PMIT is small-size ESBC with the scope of obtaining similar efficacy as surgery. Minimally invasive treatments are convenient alternatives with promising effectiveness, lower morbidity, less cost, less scarring and pain, and more satisfying cosmetic results. Ablative techniques used in BC are cryoablation, radiofrequency ablation, microwave ablation, high-intensity focused ultrasound (US), and laser ablation. The aim of our study is to discuss the current status of percutaneous management of BC, evaluate the clinical outcomes of PMIT in BC, and analyze future perspectives regarding ablation therapy in BC.

Indexed as

Ablation TechniquesBreast NeoplasmsCatheter AblationCryosurgeryHigh-Intensity Focused Ultrasound AblationLaser TherapyAgedFemaleHumansbreast cancercryoablationearly stage breast cancerhigh intensity focused ultrasoundlaser ablationmicrowave ablationminimally invasive ablationradiofrequency ablation

Identifiers

PMID36916200
PMCPMC10017926

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.